Search by Blog
Read by Category

Your healing journey continues beyond this blog

Find the right products for better recovery at online store
Cart Image
The Future of IV Cannulation Velfix® IV Kit

Vascular access in surgical settings is virtually indispensable. The intravenous administration of fluids, medications, blood products and parenteral nutrition, whether peripherally or centrally, is a routine practice in healthcare setups.

The same has been documented in several medical journals such as The American Journal of Epidemiology and the Annals of Pharmacotherapy. According to which, up to 80% of hospitalised patients in recent medical practice receive intravenous therapy while they are admitted.

Peripheral intravenous cannulation (PIVC) is the most widely used method for intravenous therapy. Although insertion of cannula and subsequent intravenous therapy are generally well tolerated, complications may arise that may lead to a prolonged hospitalisation. These complications may include Catheter-related bloodstream infections (CR-BSI), Bruising & vein irritation or Blockage. 

Fact:
Epidemiological studies from Europe and US region indicate the incidence of CR-BSI as a percentage of catheters inserted, is between 3% and 7%. (Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention and management. In: Bison AL, Waldvogel FA, eds. Infections associated with medical devices. Washington DC: ASM Press, 1994:155–205.)

It is vital to understand that any procedure that punctures the skin comes with a risk of associated infections. Since IV sits directly in your bloodstream, a regular observation of the IV site and strict procedures to prevent infection must be practiced by the nursing staff. These will include maintaining good aseptic techniques to minimise the risk of local and systemic infections. 

The CDC Guidelines:

The Centers for Disease Control and Prevention (CDC) have issued certain Guidelines For The Prevention Of Intravascular Catheter-Related Infections. These have been developed for healthcare personnel who insert intravascular catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home healthcare settings.

These guidelines include Selection of Catheters; Hand Hygiene & Aseptic Techniques; Maximal Sterile Barrier Precautions; Skin Preparation; Catheter Site Dressing Regimens; Cleansing; Catheter Securement Devices etc.

  • It is recommended to prepare a clean skin with an antiseptic (70% alcohol, tincture of iodine, an iodophor or chlorhexidine gluconate) before peripheral venous catheter insertion.
  • The use of either a sterile gauze or sterile, transparent, semipermeable dressing to cover the catheter site are recommended.
  • It is also suggested to monitor the catheter sites visually when the dressings are changed or by palpation through an intact dressing on a systematically, depending on the clinical situation of each patient. 

We have introduced a high utility, highly effective IV Cannulization dressing kit specially designed to take care of insertion & dressing change of peripheral vascular devices. 

VELFIX®-IV KIT

A sterile IV Dressing Kit for cannula fixation, including 4 contents in accordance with CDC guidelines.

  • Tourniquet: The kit comes with a latex free tourniquet which helps to identify the veins. Since it is a non-reusable tourniquet, there are a reduced chances of cross- contamination due to carrier property of Velcro tourniquets and thereby preventing skin allergy.
  • Antiseptic Swab: A 70% IPA Swab/chlorhexidine gluconate CHG swab is included in the kit which is considered ideal for skin preparation before peripheral venous catheter insertion. This falls under Category 1B as per Healthcare Infection Control Practices Advisory Committee (HICPAC) implying strong recommendation for implementation, supported by some experimental, clinical, or epidemiologic studies, a strong theoretical rationale; or an accepted practice supported by limited evidence.
  • Velfix® -Edge IV Dressing (7cm x 9cm): Transparent IV dressing with Window Frame delivery design to allow continuous observation of the IV site while providing better seal around the catheter with stabilization non-woven boarders. The notched design ensures effective stabilization of the catheter. The transparent film of the dressing serves as a waterproof sterile barrier to external contaminants. The film is breathable in nature providing high MVTR with an effective wear time of up to 7 days. The dressing comes with a hypoallergenic, latex-free adhesive that is gentle to the skin yet holds catheter in place. It offers single hand application & gentle removal.

The Sterile Gauze Swab of the Velfix® -I.V. Kit is available to control the back flash of blood.

We Datt Mediproducts understand that catheter stabilization is imperative to decrease the risk for phlebitis, catheter migration and dislodgement, and potentially in preventing CR-BSIs. Velfix-IV Kit is an effective and high utility securement device which avoids disruption around the catheter entry site and may reduce the degree of bacterial colonization also. 

Visit www.dattmedi.com for more infomation.
Share:
Recent Blogs

In the realm of wound care, continuous advancements are constantly improving the way we treat and manage various types of wounds. Among the latest innovations, Velseal® -T Disc has emerged as a game-changer. This revolutionary product offers an effective and convenient solution for promoting wound healing and enhancing patient comfort.

Understanding Velseal® -T Disc

It is a cutting-edge wound care product designed to optimize the healing process while minimizing discomfort for patients. Velseal® -T Disc promotes haemostasis by absorbing the blood and accumulates clotting factor within the voids and initiate the clotting by interaction with Thrombin, Calcium chloride and Tranexamic acid.

Key Features and Benefits:

1. Advanced Composition:

It is composed of high-quality materials that offer excellent absorption and retention capacities, reducing the risk of maceration and infection. However, it does not provide moisture balance or directly contribute to wound healing.

2. Easy Application:

Thee disc-shaped design of Velseal® -T Disc allows for simple and hassle-free application. Its non-adherent nature eliminates the need for additional fixation methods, providing a secure and comfortable fit. The dressing is available in various sizes to accommodate different wound types and locations.

3. Enhanced Patient Comfort:

It prioritizes patient comfort by minimizing pain and trauma during dressing changes. The non-adherent surface prevents the dressing from sticking to the wound bed, reducing discomfort and potential damage to healing tissue.

4. Cost-Effective Solution:

It offers a cost-effective wound care solution, as it requires no dressing changes. A single application helps in achieving complete hemostasis, contributing to overall healthcare cost savings. Its durability and prolonged wear time further enhance its cost-effectiveness.

Clinical Efficacy and Evidence

The product has undergone rigorous testing and evaluation to validate its clinical efficacy. Clinical studies have demonstrated its effectiveness in promoting faster wound healing, reducing pain, and minimizing complications such as infection. These studies highlight the dressing’s superior moisture management capabilities and its ability to facilitate granulation tissue formation, resulting in improved patient outcomes.

In the rapidly evolving field of wound care, the Velseal® -T Disc stands out as a remarkable innovation. Its unique composition, easy application, and patient-centric design make it a valuable addition to any healthcare setting. With its demonstrated clinical efficacy and cost-effectiveness, this advanced dressing offers a promising solution for healthcare professionals and patients alike. By leveraging the benefits of Velseal® -T Disc, healthcare providers can enhance wound healing outcomes and improve the overall quality of care for patients with acute or chronic wounds.

In our fast-paced and demanding modern world, it has become increasingly crucial to prioritize our health and well-being. Among the myriad of health concerns affecting millions worldwide, cancer stands as one of the most significant challenges we face. However, with advances in medical science, early detection has emerged as a powerful tool in the fight against this devastating disease. In this blog, we will explore the importance of early cancer detection, shed light on screening guidelines, and emphasize the necessity of regular screenings for various types of cancer.

The Impact of Early Cancer Detection: Early detection plays a pivotal role in improving cancer outcomes and significantly increasing the chances of successful treatment. When cancer is detected in its early stages, before it has metastasized, treatment options are often less aggressive and more effective. Moreover, early detection significantly enhances survival rates, underscoring the vital importance of regular screenings for individuals.

Screening Guidelines for Different Types of Cancer:

Breast Cancer:

Among women, breast cancer is one of the most prevalent forms of the disease. The American Cancer Society advises that women aged 40 and above should undergo annual mammograms for breast cancer screening. However, individual risk factors may warrant earlier screenings or additional tests.


Colorectal Cancer:

Affecting both men and women, colorectal cancer ranks as the third most common cancer globally. Screening for colorectal cancer typically begins at the age of 45. Methods such as colonoscopy, sigmoidoscopy, and stool-based tests are employed to detect abnormal growths or cancerous cells in the colon or rectum.

Cervical Cancer:

Regular screenings and human papillomavirus (HPV) vaccination can prevent cervical cancer. The American Cancer Society recommends cervical cancer screening for individuals with a cervix starting at the age of 25. This can be achieved through a Pap test, an HPV test, or a combination of both.

Lung Cancer:

As the leading cause of cancer-related deaths worldwide, lung cancer poses a significant threat. For individuals at high risk, such as current or former smokers, low-dose computed tomography (LDCT) scans are recommended. Screening should commence at the age of 50 and continue until age 80, or as long as the individual is in good health.


Prostate Cancer:

Primarily affecting men, prostate cancer typically develops in older individuals. The American Cancer Society advises men to discuss the potential benefits and risks of prostate cancer screening with their healthcare provider. Screening options include prostate-specific antigen (PSA) blood tests and digital rectal exams.

Early cancer detection can save lives by enabling more effective treatment options and improving survival rates. By adhering to the recommended screening guidelines for different types of cancer, individuals can take proactive steps towards their health and potentially detect cancer in its early stages.

Through raising awareness, educating the public, and advocating for regular screenings, we can work together to alleviate the burden of cancer and enhance overall healthcare outcomes. Remember, prevention and early detection are the keys to triumphing over cancer. This strategic stance promises extended lives, improved outcomes, and a brighter future for all, underscoring the vital role of early cancer detection as a beacon of hope in a world where health is paramount.

×